Introduction: The purpose of this guideline is to establish clinical practice recommendations
for the pharmacologic treatment of chronic insomnia in adults, when such treatment is …

For many years practitioners have had limited data from double-blind, placebo-controlled
studies to guide the types of decision-making needed to optimally manage patients with …

Insomnia is one of the most common and burdensome disorders in adults. We compared
and ranked insomnia medication on the basis of their efficacy and tolerability. We performed …

Description: The American College of Physicians (ACP) developed this guideline to present
the evidence and provide clinical recommendations on the management of chronic …

Background: Pharmacologic interventions are often prescribed for insomnia disorder.
Purpose: To assess the benefits, harms, and comparative effectiveness of pharmacologic …

Because the vast majority of instances involve an antidepressant dose that is subtherapeutic
for the treatment of depression, it is unlikely that physicians believe they are treating a …

Significant efforts have been made in the last decade to develop evidence-based guidelines
for the treatment of insomnia and other sleep disorders. Despite such progress, there are still …

Insomnia is the most prevalent sleep disorder in the general population, and is commonly
encountered in medical practices. Insomnia is defined as the subjective perception of …

Insomnia, a common symptom throughout the world, is characterised by difficulty initiating or
maintaining sleep or non‐restorative sleep and is associated with significant morbidity. A …

The European guideline for the diagnosis and treatment of insomnia (1) was developed by a
task force of the European Sleep Research Society, which was composed of 27 experts with …